CMS Policies Offer Opportunities For Innovation – Former Abiomed Exec
This article was originally published in The Gray Sheet
Executive Summary
CMS's policies on clinical trial coverage, Center of Excellence-restricted coverage, and determinations contingent on further data are "salutary" for developing innovative devices, according to former Abiomed exec Edward Berger